This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.
IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...
DUBLIN, Aug. 25, 2025 /PRNewswire/ -- ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the ...
Retreatment after benign prostatic hyperplasia (BPH) procedures appear lowest for men undergoing simple prostatectomy, HoLEP, ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
The MarketWatch News Department was not involved in the creation of this content. Results of 244-Patient Study to Support Planned FDA Pre-Market Approval (PMA) Application BOSTON and YOKNEAM, Israel, ...
Innovative Design Allows for Only Tailored BPH Approach that Preserves Natural Anatomy SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the U.S. Food and ...
Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...
Hosted on MSN
BPH treatment with iTind
Urologist talks about the MIST procedure called iTind for men with benign prostatic hypertrophy (BPH). Trump repeats wild Bin Laden claim that's been proven false What to know about the Venezuelan oil ...
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results